BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee J, Kim JO, Jung CK, Kim YS, Yoo IR, Choi WH, Jeon EK, Hong SH, Chun SH, Kim SJ, Kim YK, Kang JH. Metabolic Activity on [18F]-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Glucose Transporter-1 Expression Might Predict Clinical Outcomes in Patients With Limited Disease Small-Cell Lung Cancer Who Receive Concurrent Chemoradiation. Clinical Lung Cancer 2014;15:e13-21. [DOI: 10.1016/j.cllc.2013.09.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Simone CB, Houshmand S, Kalbasi A, Salavati A, Alavi A. PET-Based Thoracic Radiation Oncology. PET Clinics 2016;11:319-32. [DOI: 10.1016/j.cpet.2016.03.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
2 Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Elcim Y, Gundem E, Dirican B, Beyzadeoglu M. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective. Curr Radiopharm 2019;12:4-10. [PMID: 30465520 DOI: 10.2174/1874471012666181120162434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Incerti E, Mapelli P, Vuozzo M, Fallanca F, Monterisi C, Bettinardi V, Moresco RM, Gianolli L, Picchio M. Clinical PET imaging of tumour hypoxia in lung cancer. Clin Transl Imaging 2017;5:427-45. [DOI: 10.1007/s40336-017-0243-x] [Reference Citation Analysis]
4 Bütof R, Troost EGC. The role of functional imaging in lung cancer. Clin Transl Imaging 2018;6:441-7. [DOI: 10.1007/s40336-018-0300-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Kim H, Yoo IR, Boo SH, Park HL, O JH, Kim SH. Prognostic Value of Pre- and Post-Treatment FDG PET/CT Parameters in Small Cell Lung Cancer Patients. Nucl Med Mol Imaging 2018;52:31-8. [PMID: 29391910 DOI: 10.1007/s13139-017-0490-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
6 Zhang X, Guo M, Fan J, Lv Z, Huang Q, Han J, Wu F, Hu G, Xu J, Jin Y. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis. Cancer Biomark 2016;16:415-23. [PMID: 27062698 DOI: 10.3233/CBM-160580] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
7 Christensen TN, Langer SW, Persson G, Larsen KR, Amtoft AG, Keller SH, Kjaer A, Fischer BM. Impact of [18F]FDG-PET and [18F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics (Basel) 2021;11:279. [PMID: 33670242 DOI: 10.3390/diagnostics11020279] [Reference Citation Analysis]
8 Jones GS, Elimian K, Baldwin DR, Hubbard RB, McKeever TM. A systematic review of survival following anti-cancer treatment for small cell lung cancer. Lung Cancer 2020;141:44-55. [PMID: 31955000 DOI: 10.1016/j.lungcan.2019.12.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
9 Petrelli F, Cabiddu M, Coinu A, Borgonovo K, Ghilardi M, Lonati V, Barni S. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol 2015;54:961-70. [PMID: 25984930 DOI: 10.3109/0284186X.2015.1043026] [Cited by in Crossref: 107] [Cited by in F6Publishing: 70] [Article Influence: 15.3] [Reference Citation Analysis]
10 Quartuccio N, Salem A, Laudicella R, Spataro A, Chiaravalloti A, Caobelli F, Cistaro A, Alongi P, Evangelista L. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review. Nucl Med Commun 2021;42:839-45. [PMID: 33741854 DOI: 10.1097/MNM.0000000000001407] [Reference Citation Analysis]
11 Christensen TN, Andersen PK, Langer SW, Fischer BMB. Prognostic Value of 18F-FDG-PET Parameters in Patients with Small Cell Lung Cancer: A Meta-Analysis and Review of Current Literature. Diagnostics (Basel) 2021;11:174. [PMID: 33530446 DOI: 10.3390/diagnostics11020174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Krencz I, Sztankovics D, Danko T, Sebestyen A, Khoor A. Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations. Cancer Metastasis Rev. [DOI: 10.1007/s10555-021-10012-4] [Reference Citation Analysis]
13 Kwon SH, Hyun SH, Yoon JK, An YS, Oh YT, Choi JH, Park KJ, Lee SJ. The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer. Medicine (Baltimore) 2016;95:e2772. [PMID: 26844524 DOI: 10.1097/MD.0000000000002772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
14 Christensen TN, Langer SW, Villumsen KE, Johannesen HH, Löfgren J, Keller SH, Hansen AE, Kjaer A, Fischer BM. 18F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study. Eur J Hybrid Imaging 2020;4:2. [PMID: 34191195 DOI: 10.1186/s41824-019-0071-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lee JW, Choi JS, Lyu J, Lee SM. Prognostic significance of 18F-fluorodeoxyglucose uptake of bone marrow measured on positron emission tomography in patients with small cell lung cancer. Lung Cancer 2018;118:41-7. [PMID: 29572001 DOI: 10.1016/j.lungcan.2018.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]